Finance

Lists
NKGN:OTCMKTS
NKGen Biotech Inc
USD 0,011
0,00%
(0,00) 1D
9 Okt., 13:09:51 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKGN...
Mkt. cap
1,45 m
Avg. vol.
3,21 k
Volume
1,00
52-wk high
USD 0,20
52-wk low
USD 0,00
Beta
1,69
Shares outstanding
130,60 m
No. of employees
26
Mkt. cap
1,45 m
Avg. vol.
3,21 k
Volume
1,00
52-wk high
USD 0,20
52-wk low
USD 0,00
Beta
1,69
Shares outstanding
130,60 m
No. of employees
26
News stories
From web sources and news partners
About NKGen Biotech Inc
CEO-
Employees26
Founded2017
HeadquartersSanta Ana, Kalifornië, Verenigde State van Amerika
Sector-
Websitenkgenbiotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2024
Des. 2024
Mrt. 2025
Revenue
-
-
-
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
2,78 m
1,56 m
1,86 m
Total research and development expenses
-
-
-
Selling, general, and admin expenses
4,01 m
3,54 m
2,81 m
Operating expense
6,79 m
5,10 m
4,67 m
Total operating expenses
6,79 m
5,10 m
4,67 m
Operating income
-6,79 m
-5,10 m
-4,67 m
Other non operating income
-2,99 m
-8,79 m
20,52 m
EBT including unusual items
6,60 m
-29,36 m
15,35 m
EBT excluding unusual items
-10,25 m
-14,43 m
15,35 m
Income tax expense
-
53,00 k
-
Effective tax rate
-
-0,18%
-
Other operating expenses
-
-
-
Net income
6,60 m
-29,41 m
15,35 m
Net profit margin
-
-
-
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-472,00 k
-536,00 k
-509,00 k
Net interest expenses
-472,00 k
-536,00 k
-509,00 k
Depreciation and amortization charges
-
-
-
EBITDA
-6,49 m
-4,80 m
-4,32 m
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme